The SGLT2 inhibitor canagliflozin attenuates mitochondrial oxidative stress and alterations of calcium handling induced by high glucose in human cardiac fibroblasts
Cell Cycle · 2024
DOI: 10.1080/15384101.2025.2492423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Cycle, 2024. Verfasst von Fahimeh Varzideh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Einstein-Mount Sinai Diabetes Research Center (ES-DRC…. Hauptthemen laut MEDLINE: Oxidative Stress, Calcium, Fibroblasts, Glucose. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, the American Heart Association, the NIH.
Abstract (Originalsprache)
Cardiac fibrosis and remodeling are critical contributors to heart failure, particularly in the context of diabetes, where hyperglycemia (HG) exacerbates pathological fibroblast activity. Despite the known cardiovascular benefits of canagliflozin (CANA), its specific effects on human cardiac fibroblasts (HCFs) under HG conditions remain unexplored. We investigated whether CANA could mitigate HG-induced detrimental responses in HCFs. Dose-response assays revealed that 100 nM CANA significantly reduced HG-induced proliferation and migration of HCFs. Furthermore, CANA attenuated mitochondrial reactive oxygen species (ROS) production, a key driver of myofibroblast differentiation, and suppressed HG-induced expression of SMAD2, a critical activator of cardiac fibroblasts. Additionally, HG disrupted calcium (Ca2+) homeostasis, which was ameliorated by CANA treatment. These findings collectively demonstrate that CANA exerts protective effects on HCFs by improving mitochondrial function, restoring Ca2+ handling, and reducing fibroblast proliferation, migration, and activation under HG conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine (Division of Cardiology), Wilf Family Cardiovascular Research Institute, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research, Albert Einstein College of M…
- Department of Molecular Pharmacology, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York City, NY, USA.
ORCID-Profile: Gaetano Santulli
Förderung
- NHLBI NIH HHS
- the American Heart Association
- the NIH
Zitieren
APA
Varzideh, F., Kansakar, U., Wilson, S., Jankauskas, S. S., & Santulli, G. (2024). The SGLT2 inhibitor canagliflozin attenuates mitochondrial oxidative stress and alterations of calcium handling induced by high glucose in human cardiac fibroblasts. Cell Cycle. https://doi.org/10.1080/15384101.2025.2492423
Vancouver
Varzideh F, Kansakar U, Wilson S, Jankauskas SS, Santulli G. The SGLT2 inhibitor canagliflozin attenuates mitochondrial oxidative stress and alterations of calcium handling induced by high glucose in human cardiac fibroblasts. Cell Cycle. 2024. doi:10.1080/15384101.2025.2492423
BibTeX
@article{Varzideh2024,
author = {Varzideh, Fahimeh and Kansakar, Urna and Wilson, Scott and Jankauskas, Stanislovas S and Santulli, Gaetano},
title = {The SGLT2 inhibitor canagliflozin attenuates mitochondrial oxidative stress and alterations of calcium handling induced by high glucose in human cardiac fibroblasts},
journal = {Cell Cycle},
year = {2024},
doi = {10.1080/15384101.2025.2492423}
}
EUVIMED